Table 2.

Forty-eight-week CD4 Count Trajectory by Baseline CD4 Count at Antiretroviral Therapy Initiation With Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate

Baselinea CD4 Count, Cells/μL	CD4 Increase at 48 wkb, Median (Range)
Overallc (387; 34–747)	161 (27–547)
<200	121 (64–271)
200–350	161 (58–241)
351–500	111 (36–375)
501–750	195 (27–547)

^aBaseline = screening visit.

^bIn those individuals completing 48 weeks of antiretroviral therapy (n = 29).

^cFor all CD4 count strata.